Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  J ANTIINFECTIVES FOR SYSTEMIC USE
    J05 ANTIVIRALS FOR SYSTEMIC USE
      J05A DIRECT ACTING ANTIVIRALS
        J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
          J05AF10 Entecavir [DG:DG00661]
            D04008  Entecavir (USP) <JP/US>

USP drug classification [BR:br08302]
  Antivirals
    Anti-hepatitis B (HBV) Agents
      Entecavir [DG:DG00661]
        D04008  Entecavir (USP)

Therapeutic category of drugs in Japan [BR:br08301]
  6  Agents against pathologic organisms and parasites
    62  Chemotherapeutics
      625  Antivirals
        6250  Antivirals
          D04008  Entecavir (USP); Entecavir hydrate (JAN)

Drug groups [BR:br08330]
  Antiviral
    DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
      DG00661  Entecavir
        D04008  Entecavir

Antimicrobials [BR:br08307]
  Antivirals
    Genome replication inhibitor
      HBV reverse transcriptase inhibitor
        D04008  Entecavir (USP) <JP/US>

New drug approvals in the USA [br08319.html]
  D04008

New drug approvals in Europe [br08329.html]
  D04008

New drug approvals in Japan [br08318.html]
  D04008

New drug approvals in the USA, Europe and Japan [br08328.html]
  D04008